Search Orphan Drug Designations and Approvals
-
| Generic Name: | synthetic double-stranded siRNA oligonucleotide directed against p53 mRNA |
|---|---|
| Date Designated: | 09/25/2012 |
| Orphan Designation: | Treatment of ischemic optic neuropathy |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Quark Pharmaceuticals, Inc. 7999 Gateway Boulevard, Suite 310 Newark, California 94560 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







